View study details on clinicaltrials.gov.
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
The Citadel Embolization Device Study
The purpose of this study is to gather safety and effectiveness data on Stryker Neurovascular’s Next Generation Target Detachable Coil (hereafter referred to as the Citadel Embolization Device), when used with Target Detachable Coils, in the treatment of wide-neck intracranial aneurysms.
Location: CPMC (San Francisco: Davies Campus)
Please contact: ClinicalResearch@sutterhealth.org about study CITADEL
Fabio Settcase, M.D., M.S., FRCPC, Warren T Kim, M.D., Ph.D.
Investigator: Lawrence Dickinson, M.D
Using Electronic Health Records to Identify Gaps in Migraine Headache Care: A Step Towards Improving Patient Outcomes
Mindfulness and Migraine: A Randomized Controlled Trial
Investigator: Sylvia Sudat, PhD